For the Inventor, By the Inventor

Enter assignee name

Kringle Pharma Inc.

USPTO Granted Patents = 14

CIPO Patents = 6

EPO Patents = 9

Trademarks = 4

Forward Citations = 23

Loading Chart...

Loading Chart...

28 inventors (with patents filed for the assignee):

Toshikazu Nakamura (10 out of 37 patents)

Kunio Matsumoto (8 out of 11 patents)

Kazuhiro Fukuta (5 out of 7 patents)

4. Jun Amano (3 out of 7 patents)

5. Keigo Hanada (3 out of 3 patents)

6. Ken-ichi Ito (3 out of 3 patents)

7. Kazuhiro Yamaura (3 out of 3 patents)

8. Kiichi Adachi (3 out of 3 patents)

9. Hayao Inoue (2 out of 4 patents)

10. Hiroshi Funakoshi (2 out of 2 patents)

11. Daichika Hayata (2 out of 2 patents)

12. Hideyuki Okano (1 out of 27 patents)

13. Arihiko Kanehiro (1 out of 5 patents)

14. Hiroyuki Tsuchiya (1 out of 7 patents)

15. Yoshiaki Toyama (1 out of 5 patents)

14 patents: Sort by Forward Citations

1. 10702582 - HGF preparation suitable for treatment of neurological disorders (2020-07-07),

2. 10213485 - HGF preparation suitable for treatment of neurological disorders (2019-02-26),

3. 8927493 - Promoter for regeneration of tendon-bone junction tissue or ligament-bone junction tissue (2015-01-06),

4. 8575099 - Agent for treating polyglutamine aggregation-caused disease or suppressing onset thereof (2013-11-05),

5. 8518880 - Therapeutic agent for spinal cord injuries (2013-08-27),

6. 8461112 - HGF preparation (2013-06-11),

7. 8383588 - Fibrosis inhibitor for implanted organ (2013-02-26),

8. 8278270 - HGF precursor protein variant and active protein thereof (2012-10-02),

9. 8076289 - Fibrosis inhibitor for implanted organ (2011-12-13),

10. 8003607 - HGF precursor protein variant and active protein thereof (2011-08-23),

11. 7838494 - Differentiation- or regeneration-inducing agent for alveoli (2010-11-23),

12. 7807177 - Segment of glycosylation-deficient HGFalpha-chain (2010-10-05),

13. 7696170 - Fibrosis inhibitor for implanted organ (2010-04-13),

14. 7563768 - Asthma preparation (2009-07-21),

Kringle Pharma Inc. is a leading pharmaceutical company dedicated to improving the health and well-being of people around the world. With a focus on research, development, and manufacturing of innovative and high-quality medications, Kringle Pharma Inc. strives to deliver effective and safe healthcare solutions. We are committed to ensuring global access to our products, and our team of highly skilled professionals relentlessly pursues breakthrough discoveries and advancements in the field of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

14 Patents

#331 in Osaka

#3,488 in Japan

#40,959 in the World

Kringle Pharma Inc.

Forward Citations = 23

28 inventors:

Toshikazu Nakamura (10 out of 37 patents)

Kunio Matsumoto (8 out of 11 patents)

Kazuhiro Fukuta (5 out of 7 patents)

4. Jun Amano (3 out of 7 patents)

5. Keigo Hanada (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…